Solid Biosciences Ownership | Who Owns Solid Biosciences?
Solid Biosciences Ownership Summary
Solid Biosciences is owned by 11.94% institutional investors, 0.52% insiders, and 87.54% retail investors. Perceptive advisors is the largest institutional shareholder, holding 12.57% of SLDB shares. Fidelity Select Biotechnology is the top mutual fund, with 3.68% of its assets in Solid Biosciences shares.
SLDB Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Solid Biosciences | 11.94% | 0.52% | 87.54% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Perceptive advisors | 11.83M | 12.57% | $73.01M |
| Bain capital life sciences investors | 7.91M | 8.40% | $48.81M |
| Siren | 7.42M | 7.88% | $45.76M |
| Ra capital management | 5.81M | 6.17% | $35.86M |
| Blackrock funding, inc. /de | 4.73M | 5.02% | $29.15M |
| Adage capital partners gp | 4.00M | 4.25% | $24.68M |
| Vanguard group | 3.08M | 3.28% | $19.03M |
| Vestal point capital, lp | 2.98M | 3.16% | $18.36M |
| Fmr | 2.91M | 3.10% | $17.98M |
| Redmile group | 1.90M | 2.02% | $11.72M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Bain capital life sciences investors | 7.91M | 3.24% | $48.81M |
| Sectoral asset management | 633.05K | 2.41% | $3.91M |
| Perceptive advisors | 11.83M | 2.11% | $73.01M |
| Ally bridge group (ny) | 549.18K | 2.06% | $3.39M |
| Siren | 7.42M | 1.79% | $45.76M |
| Bioimpact capital | 1.63M | 1.65% | $10.09M |
| Birchview capital, lp | 296.95K | 1.38% | $1.83M |
| Boxer capital management | 600.00K | 1.18% | $3.70M |
| Redmile group | 1.90M | 1.14% | $11.72M |
| Vestal point capital, lp | 2.98M | 0.83% | $18.36M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vestal point capital, lp | 2.98M | 0.83% | 1.47M |
| Boxer capital management | 600.00K | 1.18% | 600.00K |
| Armistice capital | 936.00K | 0.09% | 536.00K |
| Renaissance | 463.70K | 0.00% | 463.70K |
| Panagora asset management | 397.19K | 0.01% | 397.19K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Commodore capital lp | - | - | -5.83M |
| Adage capital partners gp | 4.00M | 0.04% | -2.73M |
| Vr adviser | - | - | -2.48M |
| Monashee investment management | - | - | -2.17M |
| Casdin capital | - | - | -775.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Panagora asset management | 397.19K | 0.01% | 397.19K | $2.45M |
| Parkman healthcare partners | 396.40K | 0.26% | 396.40K | $2.45M |
| Skopos labs | 99.58K | 0.07% | 99.58K | $614.44K |
| Jane street group | 91.59K | 0.00% | 91.59K | $565.09M |
| Schonfeld strategic advisors | 68.00K | 0.00% | 68.00K | $419.57K |
Sold Out
| Holder | Change |
|---|---|
| Clearstead advisors | -9.00 |
| Td waterhouse canada | -180.00 |
| Coldstream capital management | -685.00 |
| Smartleaf asset management | -800.00 |
| Belvedere trading | -901.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 47 | -55.66% | 11,240,036 | -85.75% | 11 | 0.17% | 22 | -68.57% | 15 | 7.14% |
| Jun 30, 2025 | 24 | -81.10% | 2,819,669 | -96.42% | 4 | 0.03% | 17 | -81.32% | 3 | -82.35% |
| Mar 31, 2025 | 127 | 33.68% | 78,847,007 | 117.02% | 193 | 2.44% | 91 | 78.43% | 17 | -5.56% |
| Dec 31, 2024 | 1 | - | 7 | - | - | - | - | - | - | - |
| Sep 30, 2024 | 1 | - | 7 | - | - | - | - | -100.00% | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Select Biotechnology | 2.87M | 3.68% | -305.10K |
| Vanguard Total Stock Mkt Idx Inv | 1.87M | 2.41% | -41.42K |
| iShares Russell 2000 ETF | 1.58M | 2.03% | - |
| Franklin Biotechnology Discv A(acc)USD | 1.03M | 1.33% | - |
| Vanguard US Total Market Shares ETF | 854.68K | 1.12% | - |
| Fidelity Small Cap Index | 663.26K | 0.85% | 421.06K |
| Vanguard Institutional Extnd Mkt Idx Tr | 642.62K | 0.83% | -299.52K |
| International Biotechnology Ord | 582.01K | 0.75% | - |
| iShares Russell 2000 Value ETF | 572.56K | 0.74% | - |
| Franklin Biotechnology Discovery A | 566.70K | 0.73% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 03, 2025 | Howton David T | Chief Operating Officer | Sell | $25.20K |
| Dec 03, 2025 | Cumbo Alexander | President and CEO | Sell | $55.23K |
| Dec 03, 2025 | Hanrahan Jessie | Chief Regulatory Officer | Sell | $22.91K |
| Dec 03, 2025 | Herzich Paul | Chief Technology Officer | Sell | $13.80K |
| Nov 10, 2025 | Ganot Ilan | - | Sell | $13.51K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 6 |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | 6 | 10 |
| 2024 Q4 | - | 5 |
SLDB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools